CyberIntel ⬡ News
★ Saved ◆ Cyber Reads
← Back 🔍 Digital Forensics May 19, 2026

Cellebrite Q1 Adjusted Earnings, Revenue Rise; Issues Q2, 2026 Revenue Guidance; Shares Fall Pre-Bell - Moomoo

Moomoo Archived May 19, 2026 ✓ Full text saved

Cellebrite Q1 Adjusted Earnings, Revenue Rise; Issues Q2, 2026 Revenue Guidance; Shares Fall Pre-Bell Moomoo

Full text archived locally
✦ AI Summary · Claude Sonnet


    Accessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window Clear Log in to access Online Inquiry Back to the Top To create a seamless experience and for website quality and improvement purposes, we use cookie technologies for verification and quality purposes, to personalize the content presented, and to provide advertising that may be of specific interest to you. Learn our Privacy Policy here. Accept All Reject All Headlines Cellebrite Q1 Adjusted Earnings, Revenue Rise; Issues Q2, 2026 Revenue Guidance; Shares Fall Pre-Bell Cellebrite Q1 Adjusted Earnings, Revenue Rise; Issues Q2, 2026 Revenue Guidance; Shares Fall Pre-Bell MT Newswires ·  May 14 07:27 CLBT +5.01% Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share. Login or create a forever free account to read this news Sign up/Log in Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more Like Views 290 Recommended Pavonine to Retire KRW7.5 Billion Worth of Treasury Shares; Shares Decline 3% MT Newswires · 14m CareTrust REIT Expects Gross Proceeds of Approximately $509.4M From Upsized Public Offering >CTRE Dow Jones · 24m Alterity Therapeutics Says Data Presentations Support Phase Three Development for Multiple System Atrophy Treatment Candidate MT Newswires · 19m Roche Expands Access to Influenza Drug Xofluza Via License Deal With MPP MT Newswires · 19m StanChart Lays Out Plan for 18% Return, Corporate Job Cuts -- Update WSJ · 9m Write a comment No comments yet. Write one.
    💬 Team Notes
    Article Info
    Source
    Moomoo
    Category
    🔍 Digital Forensics
    Published
    May 19, 2026
    Archived
    May 19, 2026
    Full Text
    ✓ Saved locally
    Open Original ↗